SA Pharmaceutical Journal - Volume 81, Issue 2, 2014
Volume 81, Issue 2, 2014
Author Lorraine OsmanSource: SA Pharmaceutical Journal 81 (2014)More Less
I have a confession to make. During the time that I worked at the University of the Witwatersrand, I always felt as though I was a pseudo-academic. When I left school, my parents wanted me to become a teacher. As a 17 year old, I rebelled. The last thing on earth I wanted to do was to become a teacher. And deal with rebellious teenagers? Absolutely not! So I went straight into medical technology, and found that I loved medical microbiology. Bugs were much more interesting to me than kids. However, eventually I needed a new career, and decided that pharmacy was an excellent option. It was. I fell in love with organic chemistry on the first day that I attended class. It took a bit longer with the other courses, but I knew that I was in the right place at the right time for me.
Author Johann KrugerSource: SA Pharmaceutical Journal 81 (2014)More Less
I recently had the opportunity of addressing a branch annual general meeting, and under the item "General", members were given the opportunity to have their say. A senior member in years stood up and made a moving speech of how pharmacists used to be respected in the old days, and that pharmacy as a career was an esteemed profession. He asked the question: What is the South African Pharmaceutical Society (PSSA) doing to recover, or at least maintain that image? I am sure that perhaps this expectation is shared by many other members of the PSSA.
Author Jacky Van SchoorSource: SA Pharmaceutical Journal 81, pp 10 –14 (2014)More Less
Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV complications and NSAID-related ulceration are discussed in two articles for the purposes of this publication. The first article in this two-part series presented an update on NSAID-related CV risk. This is the second article, and provides an update on NSAIDs and gastrointestinal risk.
Author Jacqui SouterSource: SA Pharmaceutical Journal 81, pp 15 –18 (2014)More Less
Streptococcus pneumonia can cause acute, invasive bacterial infections, such as meningitis, bacteraemia and pneumonia, as well as less invasive diseases, such as sinusitis and otitis media. Infants and young children, adults over 65 years of age, and individuals with underlying medical conditions are at greatest risk of infection. Invasive pneumococcal disease can be prevented by vaccination. Infants routinely receive pneumococcal conjugate vaccines as part of the Expanded Programme on Immunisation. It is recommended that adults who are older than 65 years receive a single dose of the pneumococcal polysaccharide vaccine (PPSV23). For individuals between the ages of two and 64 years with underlying medical conditions, both pneumococcal conjugate vaccine 13 (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) may be recommended. In this article, we discuss the pneumococcal conjugate vaccines and pneumococcal polysaccharide vaccine, and when to use them in healthy individuals and in those at increased risk of invasive pneumococcal disease.
Author Haley SmithSource: SA Pharmaceutical Journal 81, pp 22 –25 (2014)More Less
Dealing with the challenges of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) continues to be a major global and regional health priority. An estimated 3.4-million children were living with HIV by the end of 2011. The majority of these affected children reside in the developing world, with approximately 91% in sub-Saharan Africa. Most of these children acquire HIV from their HIV-infected mothers during pregnancy, birth or breastfeeding. With efficacious interventions, the risk of mother-to-child HIV transmission may be reduced. Advances in treatment and prevention of HIV infection have resulted in dramatic improvements in the morbidity and mortality of HIV-infected children.
Source: SA Pharmaceutical Journal 81, pp 30 –31 (2014)More Less
In terms of the requirements of the Pharmacy Act, it is the responsibility of the South African Pharmacy Council (SAPC) to establish, develop, maintain and control universally acceptable standards in pharmaceutical education and training. In order to embrace changes in the pharmaceutical and healthcare fields, the SAPC re-engineered the curriculum requirements which were implementable by schools of pharmacy in 2013.
Author Stephan MollerSource: SA Pharmaceutical Journal 81, pp 32 –33 (2014)More Less
Once in a blue moon humanity is blessed with individuals who have the unique ability of making sense of life's most perplexing questions. A search for understanding the dichotomous cliché "change is the only constant" and perhaps more accurately, why change is painful, yet necessary, led me to CS Lewis, who captured the essence of the answer to my question with a few words, that together, unfold to reveal a vivid and understandable explanation way beyond its literal understanding.
"It may be hard for an egg to turn into a bird. It would be a jolly sight harder for it to learn to fly while remaining an egg. We are like eggs at present. And you cannot go on indefinitely being just an ordinary, decent egg. We must be hatched or go bad".- CS Lewis
Author Kobus Le RouxSource: SA Pharmaceutical Journal 81, pp 34 –35 (2014)More Less
It is now time to decide what the ongoing role of the CPS will be in the future. The roles of the CPS need to be defined to establish operating procedures that will form the platform for engagement with community pharmacists, including pharmacists working in the corporate pharmacy groups and chain groups.
Author Clive StantonSource: SA Pharmaceutical Journal 81 (2014)More Less